arrow
H

Hao-Chien Wang

national taiwan university
H指数:38
被引数:4,576

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High Serum IgE is Associated with Risk of Severe Exacerbations Among Non-Eosinophilic Bronchiectasis

高血清IgE与非嗜酸性支气管扩张患者严重急性加重风险相关

Lung
IF3.9
2026-04-270
OAAI
Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the Taiwan Bronchiectasis Research Collaboration

心血管疾病作为非囊性纤维化支气管扩张患者死亡率的预后因素:来自台湾支气管扩张研究协作组的数据

2025-11-170
PRE
Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)

台湾慢性肺移植物抗宿主病共识:台湾血液与骨髓移植学会(TBMT)和台湾胸腔与重症医学学会(TSPCCM)联合声明

2025-09-090
OAAI
Association of T-cell immunoglobulin and mucin domain-3 gene (TIM3) polymorphism with susceptibility and severity of Mycobacterium avium complex lung disease: a prospective study in Taiwan.

T细胞免疫球蛋白和黏蛋白域-3基因(TIM3)多态性与鸟分枝杆菌复合体肺部疾病易感性和严重程度的相关性:一项在台湾进行的前瞻性研究。

2025-08-200
OAAI
Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly

亚洲心血管风险患者的COPD管理:亚太呼吸学会COPD分会综述

2025-08-110
OAAI
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

生物制剂启动对口服糖皮质激素使用的影响:国际重症哮喘注册登记研究与国际患者护理研究数据库的真实世界数据合并分析

2025-04-260
OAAI
Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study

非处方短效 β2受体激动剂购买与哮喘相关健康结局: SABINA III研究的事后分析

2024-11-011
OAAI
Validating the ROSE criteria for COPD-Bronchiectasis coexistence in East Asian populations: Data from Taiwan Bronchiectasis Research Collaboration (TBARC)

验证东亚人群中COPD-支气管扩张共存的ROSE标准: 来自台湾支气管扩张研究合作组织 (TBARC) 的数据

2024-10-300
PRE
Correlating Reiff Scores with Clinical, Functional, and Prognostic Factors: Characterizing Non-Cystic Fibrosis Bronchiectasis Severity - Validation from a Nationwide Multicenter Study in Taiwan
2024-10-300
PRE
TCOG T5221 trial: A phase II randomized study of gemcitabine and nab-paclitaxel in combination with S-1/LV (GASL) or oxaliplatin (GAP) as first-line treatment for metastatic pancreatic cancer

TCOG T5221试验:一项关于吉西他滨和nab-紫杉醇联合S-1/亚叶酸钙(GASL)或奥沙利铂(GAP)作为转移性胰腺癌一线治疗的随机Ⅱ期研究

2024-09-010
PRE
Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis
2024-07-181
OAAI
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
2024-02-0112
OA
The prognostic value of blood eosinophils.monocyte count and Neutrophils/Lymphocyte ratio (NLR) in patients with IPF, CPFE and COPD:A retrospective multicenter cohort study

血嗜酸性粒细胞计数、中性粒细胞/淋巴细胞比值 (NLR) 在IPF、CPFE和COPD患者中的预后价值: 一项回顾性多中心队列研究

2023-10-270
PRE